Chemoinformaics analysis of 3,4-DIMETHOXY-BENZOIC ACID
| Molecular Weight | 182.175 | nRot | 3 |
| Heavy Atom Molecular Weight | 172.095 | nRig | 7 |
| Exact Molecular Weight | 182.058 | nRing | 1 |
| Solubility: LogS | -2.264 | nHRing | 0 |
| Solubility: LogP | 1.7 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 24.9059 |
| nHD | 1 | BPOL | 14.3721 |
| QED | 0.767 |
| Synth | 1.347 |
| Natural Product Likeliness | -0.033 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.007 |
| CACO-2 | -4.829 |
| MDCK | 0.0000116 |
| BBB | 0.6 |
| PPB | 0.392236 |
| VDSS | 0.311 |
| FU | 0.456172 |
| CYP1A2-inh | 0.046 |
| CYP1A2-sub | 0.907 |
| CYP2c19-inh | 0.039 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.018 |
| CYP2c9-sub | 0.259 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.14 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.111 |
| CL | 7.305 |
| T12 | 0.935 |
| hERG | 0.052 |
| Ames | 0.011 |
| ROA | 0.061 |
| SkinSen | 0.112 |
| Carcinogencity | 0.053 |
| EI | 0.979 |
| Respiratory | 0.083 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.86219 |